The difference is receptor responsiveness
When ARA-290 binds to the IRR, it does two critical things: It shuts down inflammation: It tells the immune system to stop attacking the damaged area, switching the focus from "defense" to "reconstruction." It stimulates regeneration: It promotes the sprouting of small nerve fibers, which are often the first to die in conditions like Small Fiber Neuropathy (SFN)
But what if the real challenge starts with controlling hunger
[3] Despite its therapeutic potential, LL-37 faces several limitations for clinical use
In this unnumbered style answer, we will discuss the use of glutathione for different skin types, including oily, dry, combination, and sensitive skin
This is a different pathway entirely, addressing the efficiency with which cells produce and use energy rather than directly targeting fat stores